Gene therapy tested as new weapon against spreading kidney cancer
NCT ID NCT06716853
Summary
This study tested the safety and early effects of a single dose of Temferon, a new type of gene therapy, in people with advanced kidney cancer that had spread and stopped responding to standard treatments. Temferon uses a patient's own modified stem cells to deliver an anti-cancer signal (interferon) directly to tumors. The trial was small and early-stage, aiming to see if the treatment was safe and showed any biological activity against the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLEAR CELL RCC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ospedale San Raffaele
Milan, Italy, 20132, Italy
Conditions
Explore the condition pages connected to this study.